Mental health issues have a severe impact on employees overall health and productivity of your employees. Yet today’s commonly prescribed mental health solutions are inadequate, with antidepressants only working for about 15% of the people who take them.
The result? Costly, ineffective treatment and an overall increase in your organization’s direct and indirect costs in healthcare.
Ketamine therapy, meanwhile, has been repeatedly shown to achieve dramatically improved outcomes with depression, PTSD, substance abuse and acute anxiety.
This can result in tangible benefits across the organization including improved productivity, lower direct and indirect medical expenses, and increased retention.
Proven effectiveness
Current treatment options including traditional therapy and antidepressants are expensive and may not have lasting effects. Research has shown psychedelic medicine to have has rapid and large reductions in depression, with 8 out of 10 participants feeling better in one month or less.
Affordable costs
Unlike the mounting annual costs from traditional therapy and medications that can reach as high $15,000/year, ketamine therapy has a finite cycle and is less than a third of the cost.
Safe and reliable
Unlike traditional therapies, there are no severe side effects like those that come along with many antidepressants. For instance, Ketamine has been studied for over 50 years and is approved nationwide.
Adoption is simple
Enthea is 100% compatible with your current benefit plan. Plus, our innovative payment platform and employee onboarding process ensures a seamless and anonymous experience for your team.
Employees who strongly agree that their employer cares about their overall well-being are 69% less likely to actively search for a new job and three times more likely to be engaged at work.
Moreover, Psychedelic therapy brings employees hope and Enthea is the only third party administrator of benefit plans for ketamine therapy. We are building the nation’s largest provider network so that you you can bring this effective treatment to your employees at a fraction of the cost of traditional treatments.
“Even though Ketamine-Assisted Therapy can have profound benefits, it often comes with a hefty price tag. I definitely would not have been able to afford this type of treatment for myself, so the fact that Dr. Bronner’s covered 100% of the treatment for me and my family was absolutely awesome!”
Enthea provides employers with:
1.
Decrease in disability claims, leading to reduced medical costs.
2.
Increased employee satisfaction and engagement.
3.
Reduced absenteeism, ensuring a more productive workforce.
4.
Decrease in employee turnover rates, fostering a loyal and dedicated workforce.
Begin by addressing conditions that visibly impact your employees, including both the individuals with the condition and their co-workers. However, keep in mind that many conditions may not be easily noticeable, so consider prevalence data from the general population as well. Finally, refer to the Level of Evidence provided in the Summary & Terms document available from Enthea to guide your decision-making.
Enthea respects your privacy and will not share your information with any other parties without your explicit consent. Our entire organization adheres to all applicable privacy laws, and we diligently safeguard your personal health information using modern security best practices and standards. For more information, please refer to our Privacy Policy.
Yes, every clinician and provider in the Enthea network is licensed by the appropriate professional boards or organizations in their practicing states, including DEA licensure and national board certification in psychiatry.
We can integrate with existing platforms like Aetna, Just Works, or ADP by receiving a data feed or making a web service call to sync membership data (which will include employees and covered dependents). In the future, we plan to offer an optional service to analyze employee absenteeism and medical expenses data, assessing the impact of ketamine-assisted therapy treatment on these key metrics. This will require additional integrations and we will announce this feature when it is possible.
The out of pocket cost for ketamine-assisted therapy can vary greatly depending on the provider, location and type of treatment being administered. Generally speaking, ketamine infusions for depression usually cost between $400-$800 per infusion. Some clinics offer discounts or membership programs to help reduce the cost of multiple treatments over time. Additionally, some clinics may accept insurance or offer payment plans to help make the treatment more affordable.
Yes, employees can use HSA or FSA funds to pay for these services, as well as HRA funds. Ketamine-assisted therapy is a permitted expense under current regulatory guidance for HRA/HSA/FSA. However, for HRAs, employers must explicitly add this treatment to the company's HRA plan.
The cost of coverage depends on several factors, including the specific conditions covered, co-pay amounts, and the percentage of benefits covered by the insurance plan. To determine the exact cost of coverage for your situation, talk to an Enthea team member today to understand coverage scenarios that fit for you.
The cost of a co-pay is dependent on several factors, including the specific conditions covered and the percentage of benefits covered by the insurance plan. To determine the exact cost of your co-pay, visit the portal or talk to an Enthea team member today to understand your specific scenario.
Enthea currently covers Ketamine Assisted Psychotherapy (KAP), a therapeutic approach that combines psychotherapy with ketamine experiences or sessions to treat psychiatric disorders. This differs from ketamine clinics that solely administer the drug without incorporating psychotherapy.
Not likely at this time, though we expect it will once this becomes more broadly accepted. There are instances of the patient getting their ketamine medicine paid for, but this seems rare for now. Ketamine prescription costs are very small relative to costs of the psychotherapy and administering the drug.
This is more than just another kind of therapy. Enthea’s mission is to create fair & equal access to this innovative treatment.
We want our providers to feel just as connected, heard, and understood as their patients. Above all things, we promise to be available, to listen, and be easy to work with.
As a public benefit corporation, our mission of safe and affordable psychedelic healthcare is what guides us — we can’t do that without exceptional providers like you.
